Key Drivers
- Margin Pressure
- Strong Liquidity
- High Intangibles
AIAI Summary
ITGR should now be viewed as a special-situation stock rather than a steady medtech compounder: the strategic review creates upside optionality, but slowing margins, muted 2026 guidance, and meaningful debt mean the equity likely stays range-bound unless management delivers a clear operating inflection or a credible transaction.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Pressure
- •Strong Liquidity
- •High Intangibles
ITGR looks fundamentally stable with decent profitability and strong liquidity, but thin margins, heavy intangibles, low cash versus debt, and a full valuation limit upside.
Price Behavior
Key Price Behavior Insights:
- •Range-Bound Drift
- •Clear Support
- •Failed Breakout
Over the last month, ITGR has been range-bound with mild weakness, holding $84-$85 support but repeatedly stalling at $89.50-$90.20, so the setup stays neutral-to-negative unless it reclaims resistance.
Latest rally failed as price slipped from $89.82 on 2026-05-14 to $88.16 on 2026-05-15
Sentiment & News
Key News Insights:
- •Strategic review
- •Revenue strength
- •Litigation risk
Integer Holdings rallied as its board launched a strategic review that could lead to a sale or merger, while mixed Q1 results showed an EPS miss offset by stronger revenue and rising buyout speculation.
The stock's near-term upside is being driven by takeover optionality, but earnings pressure and governance concerns may keep volatility elevated
Similar Companies in Healthcare
Other companies in the same sector with AI ratings